What is Floreo?
Floreo, Inc. operates as a leading science-backed virtual reality platform designed to teach essential social, communication, and life skills to individuals with Autism Spectrum Disorder (ASD). The company's proprietary technology utilizes a patented process that integrates software with virtual reality headsets. This allows for supervised, interactive, and engaging real-world scenarios, effectively building skills in critical areas of cognitive intervention. Based in Washington D.C., Floreo aims to provide innovative and accessible therapeutic tools for a demographic often underserved by traditional educational methods.
How much funding has Floreo raised?
Floreo has raised a total of $10.3M across 3 funding rounds:
Debt
$150K
Debt
$156K
Series A
$10M
Debt (2020): $150K with participation from PPP
Debt (2021): $156K led by PPP
Series A (2022): $10M supported by The Disability Opportunity Fund, Felton Group, The Autism Impact Fund, and Tenfore Holdings
Key Investors in Floreo
The Disability Opportunity Fund
The Disability Opportunity Fund is a Nationally Certified CDFI dedicated to providing financial products and advisory services to improve the quality of life and build personal wealth for people with disabilities and their families, focusing on financing scalable solutions in areas such as affordable housing and vocational training centers.
The Autism Impact Fund
The Autism Impact Fund is a healthcare technology and innovation firm that invests in behavioral health, mental health, autism, and complex chronic conditions, aiming to develop solutions that improve care accessibility and employment opportunities for neurodiverse individuals.
Tenfore Holdings
Tenfore Holdings is a New York-based global investment firm specializing in growth-stage and middle-market investments across various sectors, employing a value investing approach to identify and nurture companies driving innovation and resilience.
What's next for Floreo?
The recent major strategic investment in Floreo signals a pivotal moment for the company, likely indicating a transition towards scaling its operations and further refining its technology. With a focus on enterprise-level funding, Floreo is positioned to expand its market penetration and potentially explore new therapeutic applications or partnerships. The company's commitment to a science-backed approach, combined with the immersive nature of virtual reality, suggests a continued emphasis on data-driven outcomes and measurable skill development for its users. Future developments may include enhanced content modules, broader platform accessibility, and deeper integration into educational and therapeutic ecosystems.
See full Floreo company page
